FDA Clears 3-Minute Brain Stimulation Protocol For Depression

The U.S. Food and Drug Administration (FDA) recently cleared MagVenture’s Transcranial Magnetic Stimulation (TMS) treatment for people battling severe depression. MagVenture, a Danish company, specializes in non-invasive magnetic stimulation systems for the treatment of major depressive disorder, and is the only TMS provider in the United States.

MagVenture’s new TMS form, known as Theta Burst Stimulation (TBS), treatment is expected to reduce treatment time to just three minutes per session, up to a 34 minute decrease from the norm. The company, dubbing TBS as “expression TMS,” states that the new treatment is just as effective for . . .